Logan A. Walsh

11.4k citations
55 papers · 3.4k indexed · 2 hit papers · h-index 26

Logan A. Walsh

53 papers receiving 3.4k citations

Hit Papers

Neoadjuvan...8920122026201620214008001.2k

Peers

Logan A. Walsh
Comparison fields: 5 of 114
  • Genetics 868
  • Cancer Research 1.1k
  • Oncology 979
  • Immunology 697
  • Molecular Biology 1.7k
Replace Motoo Nagane with:
Motoo Nagane Japan
Tatsuya Ozawa Japan
Esther Hulleman Netherlands
Juan Manuel Sepúlveda-Sánchez Spain
Robert Soriano United States
Xiaoguang Fang United States
Tim Demuth United States
Keishi Makino Japan
Marta Pàez‐Ribes United Kingdom
Jason T. Huse United States
Logan A. Walsh relative to Motoo Nagane Japan Motoo Nagane's profile →
Citations per field
00.5×
Motoo Nagane · 1×
Citations per year

Countries citing papers authored by Logan A. Walsh

Since Specialization
Citations

This map shows the geographic impact of Logan A. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Logan A. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Logan A. Walsh more than expected).

Fields of papers citing papers by Logan A. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Logan A. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Logan A. Walsh. The network helps show where Logan A. Walsh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Logan A. Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Logan A. Walsh Line = papers co-authored together Logan A. Walsh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20259
2 20236
3 202357
4 20237
5 20237
6 202389
7 20225
8 202120
9 20201
10 2019202
11 201971
12 2016135
13 2016101
14 2014119
15 201432
16 201234
17 201235
18
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypebreakdown →
20121382
19 20079
20 200710

About Logan A. Walsh

Logan A. Walsh is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 55 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immune cells in cancer (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers), Cancer Cells and Metastasis (6 papers), Protease and Inhibitor Mechanisms (6 papers), Cell Adhesion Molecules Research (6 papers), Glioma Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Genetics (868 citations), Cancer Research (1.1k citations) and Oncology (979 citations). Logan A. Walsh has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Daniela F. Quail, Şevin Turcan, Luc G.T. Morris, Timothy A. Chan, Jason T. Huse, Agnès Viale, Olga A. Guryanova, Emrullah Yilmaz, Timothy A. Chan and Armida W. M. Fabius. Their work appears in journals such as Nature, Nature Communications and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026